Speed Medical results, Q3 2022
Net profit, assets, equity and cash flow for Q3 2022, against the same period a year earlier, from the published financial statements.
Net profit-146 millionEGP · −207.4% vs the same period a year earlier
Total assets606 millionEGP · −22.6% vs the same period a year earlier
Shareholders' equity282 millionEGP · −38.4% vs the same period a year earlier
Operating cash flow9.87 millionEGP · −93.3% vs the same period a year earlier
In short
- Speed Medical's net profit for Q3 2022 was about -146 million EGP, down −207.4% from 136 million EGP in Q3 2021.
- Total assets at the end of Q3 2022 were about 606 million EGP, and shareholders' equity about 282 million EGP.
- Operating cash flow for Q3 2022 was positive at 9.87 million EGP.
Key lines against the same period a year earlier
This periodQ3 2021Change
Net profit-146 million136 million−207.4%
Gross profit13.28 million213 million−93.8%
Total assets606 million783 million−22.6%
Total liabilities324 million325 million−0.4%
Shareholders' equity282 million458 million−38.4%
Total liabilities and equity606 million783 million−22.6%
Operating cash flow9.87 million148 million−93.3%
Investing cash flow-50.21 million-400 million+87.4%
Financing cash flow-53.87 million147 million−136.7%
Net change in cash-94.21 million-106 million+10.8%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Speed Medical's Q2 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy